Even among Latinx Californians, COVID-19 risk is not evenly shared, analysis finds

By Cameron Scott on March 02, 2021
More than a year into the COVID-19 pandemic that upended life as we knew it, there’s still a lot we don’t know about how many people have fallen ill and exactly what has put some people – notably those who are Black or Latinx – at higher risk of infection and death.

University of California Health and CDPH to accelerate data modeling for evidence-based public health decision making

March 02, 2021
University of California Health (UCH) and the California Department of Public Health (CDPH) are launching an innovative data modeling consortium to ensure public health policy makers have timely, relevant analysis and insights to support pandemic-related decision making.

‘Nobody came, nobody helped’: Fears of anti-Asian violence rattle the community

By Marian Liu and Rachel Hatzipanagos, Washington Post on March 01, 2021
They gather almost every night at San Francisco’s Dragon Gate, the ornately decorated entrance to the nation’s oldest Chinatown. Armed with only whistles and pamphlets, the volunteer neighborhood patrol roams the streets, checking out ATMs and mom-and-pop shops in areas where Asian residents have...

UCSF takes on health disparities in SF and beyond with the PRISE Center

By Cameron Scott on March 01, 2021
The COVID-19 pandemic has highlighted the health disparities in UCSF’s own backyard. As part of an ongoing response, UCSF is launching the PRISE Center – short for Partnerships in Research in Implementation Science for Equity – to help reduce health disparities in San Francisco and beyond.

California COVID-related deaths research & policy briefs

By Cameron Scott on February 26, 2021
What can we learn about the pandemic by studying who died in California in 2020 and 2021, compared with prior years?

To beta-amyloid or not to beta-amyloid? An innovative meta-analysis offers new insight into Alzheimer's drugs

By Cameron Scott on February 25, 2021
A new approach from UCSF researchers will help scientists more rapidly assess whether we are on the right track for developing drugs to treat Alzheimer’s disease. Currently, medications approved for Alzheimer’s disease only help to manage symptoms but do not change the disease course.

Study estimates excess deaths in US from COVID-19 pandemic unemployment

By Laura Kurtzman on February 19, 2021
Large disparities seen by education, race, age and gender

How Can We Be Sure the New COVID-19 Vaccines Are Safe?

By Ann Brody Guy on January 14, 2021
Crucial questions, say our experts, will be when and where to get vaccinated and which vaccine will be best for you.

Frailty Is a Factor in Higher Mortality for Women Awaiting Liver Transplants

By Suzanne Leigh on January 14, 2021
More Exercise, More Protein May Narrow the Gender Gap, Researchers Say